Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?
The treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has undergone several recent advancements, leading to an increased amount of treatment options for relapsed patients. The development of immunotherapies such as anti-CD19 chimeric antigen receptor(CAR) T cells and bispecific T-ce...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2021-01-01
|
| Seria: | OncoImmunology |
| Hasła przedmiotowe: | |
| Dostęp online: | http://dx.doi.org/10.1080/2162402X.2021.1956125 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|